Tokai Optical is a proud Japanese ophthalmic lens company with a long history, however it’s a relative newcomer to the Australian optical market. That isn’t stopping the company from making a mark on the local independent scene with its premium lens portfolio. Read more
With Bausch + Lomb releasing the toric version of its enhanced enVista platform, surgeons discuss how they are improving outcomes, even in complex cases. The company is also incorporating a new generation toric formula into its lens calculator.
Zeiss is offering an increased trade-in discount on all models of its Humphrey Field Analyser 3 (HFA3) until 31 March 2022, to assist clinics with upgrading to its most advanced perimetry technology. Read more
Data from patients with a subtype of AMD enrolled in Opthea’s Phase 2b clinical trial of OPT-302 in combination with ranibizumab (Lucentis), compared to ranibizumab alone, have been presented virtually at a conference in Miami. Read more
Despite modest sales growth in the first half of the current financial year, ASX-listed Nova Eye Medical believes it’s poised for stronger returns from its glaucoma portfolio with a revamped canaloplasty device, making the technology more accessible to a broader base of ophthalmologists. Read more
Device Technologies will unveil a new ophthalmic laser portfolio at RANZCO Virtual 2022, following a fresh ANZ distribution deal with Meridian Medical. Read more
Designs For Vision (DFV) will be introducing new additions in surgery and diagnostics at RANZCO virtual, and will be celebrating the 20th birthday of OCULUS Pentacam. Expanding on a comprehensive portfolio, the supplier will be showcasing its latest technology for ophthalmic surgery, with phacoemulsification and ophthalmic microscopes. Read more
AFT Pharmaceuticals has opened a new front in its eye drop portfolio, with the introduction of a preservative-free product called Ocuzo for bacterial eye infections. Read more
After 10 extremely rewarding years leading the ProVision organisation, it is time for me to leave the wonderful industry of optometry that I’ve grown to love.
Using more than 500,000 scans from its DNEye Scanner, Rodenstock has developed a new AI calculating engine offering more precise ophthalmic lenses from the standard prescription. The company is now restructuring its lens portfolio, so its premium lenses are available to a wider market.